These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development and mechanism of γ-secretase modulators for Alzheimer's disease. Crump CJ; Johnson DS; Li YM Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767 [TBL] [Abstract][Full Text] [Related]
4. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246 [TBL] [Abstract][Full Text] [Related]
5. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure. Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478 [TBL] [Abstract][Full Text] [Related]
6. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease. Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893 [TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels. Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates. Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902 [TBL] [Abstract][Full Text] [Related]
9. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. Evin G; Zhu A; Holsinger RM; Masters CL; Li QX J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315 [TBL] [Abstract][Full Text] [Related]
11. γ-secretase modulators and presenilin 1 mutants act differently on presenilin/γ-secretase function to cleave Aβ42 and Aβ43. Okochi M; Tagami S; Yanagida K; Takami M; Kodama TS; Mori K; Nakayama T; Ihara Y; Takeda M Cell Rep; 2013 Jan; 3(1):42-51. PubMed ID: 23291095 [TBL] [Abstract][Full Text] [Related]
12. Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys. Fischer C; Zultanski SL; Zhou H; Methot JL; Shah S; Hayashi I; Hughes BL; Moxham CM; Bays NW; Smotrov N; Hill AD; Pan BS; Wu Z; Moy LY; Tanga F; Kenific C; Cruz JC; Walker D; Bouthillette M; Nikov GN; Deshmukh SV; Jeliazkova-Mecheva VV; Diaz D; Michener MS; Cook JJ; Munoz B; Shearman MS Bioorg Med Chem Lett; 2015 Sep; 25(17):3488-94. PubMed ID: 26212776 [TBL] [Abstract][Full Text] [Related]
13. [Effect of βsheet blocking peptide H102 on APP metabolic enzymes in hippocampal brain of double transgenic AD mice]. Jiang F; Sun FX; Xu SM Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):299-303. PubMed ID: 29926633 [TBL] [Abstract][Full Text] [Related]
14. γ-Secretase and its modulators: Twenty years and beyond. Xia W Neurosci Lett; 2019 May; 701():162-169. PubMed ID: 30763650 [TBL] [Abstract][Full Text] [Related]
15. γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not. Lessard CB; Rodriguez E; Ladd TB; Minter LM; Osborne BA; Miele L; Golde TE; Ran Y Alzheimers Res Ther; 2020 May; 12(1):61. PubMed ID: 32430033 [TBL] [Abstract][Full Text] [Related]
16. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity. Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433 [TBL] [Abstract][Full Text] [Related]
17. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease. Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862 [TBL] [Abstract][Full Text] [Related]
18. Distribution and expression of Pen-2 in the central nervous system of APP/PS1 double transgenic mice. Chu Y; Peng X; Long Z; Wang K; Luo S; Sharma A; He G Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):258-66. PubMed ID: 25736404 [TBL] [Abstract][Full Text] [Related]
19. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes. Shirotani K; Tomioka M; Kremmer E; Haass C; Steiner H Neurobiol Dis; 2007 Jul; 27(1):102-7. PubMed ID: 17560791 [TBL] [Abstract][Full Text] [Related]
20. Identification of new Presenilin-1 phosphosites: implication for γ-secretase activity and Aβ production. Matz A; Halamoda-Kenzaoui B; Hamelin R; Mosser S; Alattia JR; Dimitrov M; Moniatte M; Fraering PC J Neurochem; 2015 May; 133(3):409-21. PubMed ID: 25458374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]